Recombinant human CD14 is a form of the protein that is produced using recombinant DNA technology. This involves inserting the gene that encodes CD14 into a host cell, such as HEK293 cells (Human Embryonic Kidney 293 cells), which then express the protein. The recombinant protein can be purified and used for various research and therapeutic purposes.
HEK293 cells are commonly used for the production of recombinant proteins due to their high transfection efficiency and ability to perform post-translational modifications. Recombinant human CD14 expressed in HEK293 cells is typically of high purity (>95%) and low endotoxin levels (<1 EU/µg), making it suitable for various applications such as SDS-PAGE, functional assays, and HPLC .
CD14 is involved in the innate immune response by recognizing and binding to LPS, which triggers a signaling cascade that leads to the activation of the NF-κB pathway. This results in the production of pro-inflammatory cytokines and other immune responses. The recombinant form of CD14 retains its biological activity and can be used to study these signaling pathways in vitro .
Recombinant human CD14 is used in various research applications, including: